Consensus Recommendations for the Diagnosis and Management of Well-Differentiated Gastroenterohepatic Neuroendocrine Tumours: A Revised Statement from a Canadian National Expert Group

Authors:
  • JMJ. Maroun
    J. Maroun
  • HKH. Kennecke
    H. Kennecke
  • CLC. Law
    C. Law
  • PMP. Metrakos
    P. Metrakos
  • JOJ.F. Ouellet
    J.F. Ouellet
  • RRR. Reid
    R. Reid
  • CRC. Rowsell
    C. Rowsell
  • ASA. Shah
    A. Shah
  • SSS. Singh
    S. Singh
  • SUS. Van Uum
    S. Van Uum
  • RWR. Wong
    R. Wong

Abstract
Well-differentiated neuroendocrine tumours (nets-previously called "carcinoid tumours") are relatively rare tumours originating from the diffuse neuroendocrine system; they are found most often in the bronchial or gastrointestinal systems. In Canada, gastroenterohepatic NETS represent less than 0.25% of oncology cases. Because of the relative rarity of these tumours, diagnostic and therapeutic approaches vary and are often based on individual physician experience. A number of European and North American groups have developed consensus guidelines for the diagnosis and management of well-differentiated gastroenterohepatic NETS, and in 2006, Canadian consensus guidelines were published by a Canadian expert group. The updated and expanded current Canadian guidelines are based on a consensus meeting held in Paris, France, in 2008 and are based on the most current literature.

This publication has 83 references indexed in Scilit: